Evidence map›Paper›PMID 23686493›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance.

Jason A Cascio, Cara L Haymaker, Rohit D Divekar, Sarah Zaghouani, Marie-Therese Khairallah, Xiaoxiao Wan, Linda M Rowland, Mermagya Dhakal, Weirong Chen, Habib Zaghouani

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jason A CascioDepartment of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO 65212, USA.
Cara L Haymaker
Rohit D Divekar
Sarah Zaghouani
Marie-Therese Khairallah
Xiaoxiao Wan
Linda M Rowland
Mermagya Dhakal
Weirong Chen
Habib Zaghouani
University of Missouri · USMelanoma Institute Australia · AUThe University of Texas Medical Branch at Galveston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kathrin Milbury · 1985 to 2026
$290.8M
Training Program in Cancer ImmunobiologyT32CA009598 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ALLISON, JAMES P · 1988 to 2014
$4.9M
Regulation of Autoimmune EncephalomyelitisR01NS057194 · NINDS · UNIVERSITY OF MISSOURI-COLUMBIA · PI ZAGHOUANI, HABIB · 2008 to 2017
$2.9M
NCI NIH HHS P30 CA016672NCI NIH HHS T32 CA009598NINDS NIH HHS R01 NS057194
6 · The paper itself

Abstract

Dendritic cells (DCs) have been shown to play a major role in oral tolerance, and this function has been associated with their ability to produce anti-inflammatory cytokines and to induce suppressive regulatory T cells. In this study, we demonstrate that upon oral administration of Ag, lamina propia (LP) DCs engage specific T cells and acquire a novel mechanism by which they transfer tolerance against diverse T cell specificities. Indeed, when Ig-myelin oligodendrocyte glycoprotein (MOG) carrying the MOG(35-55) epitope was orally administered into either T cell-sufficient or -deficient mice, only the T cell-sufficient hosts yielded CD8α(+) and CD8α(-) LP DCs that were able to transfer tolerance to a variety of MHC class II-restricted effector T cells. Surprisingly, these LP DCs upregulated programmed cell death ligand 1 during the initial interaction with MOG-specific T cells and used this inhibitory molecule to suppress activation of T cells regardless of Ag specificity. Furthermore, oral Ig-MOG was able to overcome experimental autoimmune encephalomyelitis induced with CNS homogenate, indicating that the DCs are able to modulate disease involving diverse T cell specificities. This previously unrecognized attribute potentiates DCs against autoimmunity.

Indexed as

Administration, OralAdoptive TransferAnimalsAutoantigensAutoimmunityCD4-Positive T-LymphocytesCell SeparationDendritic CellsEncephalomyelitis, Autoimmune, ExperimentalEnzyme-Linked Immunosorbent AssayFlow CytometryImmune ToleranceImmunity, InnateImmunity, MucosalLymphocyte ActivationMiceAutoantigensMyelin-Oligodendrocyte Glycoproteinmyelin oligodendrocyte glycoprotein (35-55)Peptide Fragments

Identifiers

PMID23686493
PMCPMC3679289
OpenAlexW2138032602

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.